Table 1 Demographic characteristic of all patients.

From: The efficacy and safety of intravenous tranexamic acid on blood loss during total ankle replacement: a retrospective study

Variable

TXA (n = 38)

No-TXA (n = 33)

P Value

Age (years)

65.84 ± 5.63

62.66 ± 6.92

0.642

Sex (male/female)

17/21

16/17

0.814

BMI (kg/m2)

25.73 ± 1.96

26.49 ± 2.14

0.852

Ankle diagnosis (n, %)

Osteoarthritis

24 (63.16%)

21 (63.64%)

 

Post-traumatic arthritis

11 (28.95%)

9 (27.27%)

 

Other

3 (8.89%)

3 (9.09%)

 

Comorbidities (n, %)

Diabetes

6 (15.79%)

6 (18.18%)

0.788

Smoking

6 (15.79%)

7 (21.21%)

0.759

Alcoholism

7 (18.42%)

8 (24.24%)

0.574

Gout

1 (2.63%)

2 (6.06%)

0.594

Glucocorticoid usage

2 (5.26%)

1 (3.03%)

0.641

COPD

2 (5.26%)

2 (6.06%)

0.884

Side (n, %)

Right

21 (55.26%)

19 (57.58%)

 

Left

17 (44.74%)

14 (42.42%)

 
  1. COPD chronic obstructive pulmonary disease.